3 ms·
People are implying the haggling was connected to the delay, but it wasn't necessarily. As an example the UK contract with AZ had the same limitations as the EU
by raverbashing 6y ago
People are implying the haggling was connected to the delay, but it wasn't necessarily. As an example the UK contract with AZ had the same limitations as the EU one (this just came yesterday) https://www.cnn.com/2021/02/17/europe/uk-astrazeneca-vaccine-contract-details-intl/index.html https://www.cnn.com/2021/02/17/europe/uk-astrazeneca-vaccine...
Production and deployment ramp-ups contributed more to the issue (approval delay didn't help, surely!). Per absolute number of vaccines deployed the EU is behind the US and China. https://ourworldindata.org/coronavirus-data-explorer?zoomToSelection=true&time=2021-02-17..latest&country=USA~ISR~GBR~ARE~EuropeanUnion~BRA~CHN~IDN~BGD~RUS~MEX~CHL®ion=World&vaccinationsMetric=true&interval=total&smoothing=0&pickerMetric=population&pickerSort=desc https://ourworldindata.org/coronavirus-data-explorer?zoomToS...
Profit yes, but paying that much for something that had not proven itself yet, no way.
It wouldn't be 18B, it would be 48B (2 doses per person for all inhabitants - though ok maybe you don't need to vaccinate children)